Study design of ESCAPE-TRD, a long-term, comparative, randomised phase IIIb clinical trial of esketamine nasal spray in treatment resistant depression
| Autor: | Reif, A. 1, Messer, T. 2, Eckhard, P. 3, Heerlein, K. 4, Milz, R. 5, Olbrich, K. 3, Rive, B. 6, Van Dooren, G. 7, von Holt, C. 4, Wapenaar, R. 8, Godinov, Y. 9 |
|---|---|
| Zdroj: | In Neuroscience Applied 2022 1 Supplement 2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|